Skip to main content

Table 4 Baseline clinical and demographic characteristics of the study participants at the time of ART initiation

From: Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic

Characteristic

Frequency

%

Age

<=5 years

265

37.80

 

>5-10 years

200

28.53

 

>10 – 18 years

236

33.67

Gender

Female

330

47.08

 

Male

371

52.92

Next of kin

Parents

464

66.19

 

Grandmother

106

15.12

 

Other

131

18.69

Caretaker education level

None

164

23.77

Primary

251

36.38

 

Secondary

160

23.19

 

Tertiary (not university)

69

10.00

 

University

46

6.67

Past hospitalization

Yes

303

43.41

 

No

395

56.59

Episodes of

0 days

5

1.69

Hospitalization

1-2 days

188

63.51

 

≥ 3 days

103

34.80

Opportunistic infections

TB

141

20.11

Oral Candidiasis

103

14.69

CCM

5

0.71

KS

7

1.00

LIP

2

0.29

 

PCP

8

1.14

 

Esophageal

10

1.43

 

Chronic_diarrhoea

22

3.14

 

Bacterial meningitis

7

1.00

HAART regimen

EFV

391

59.24

 

NVP

269

40.76

UsedPMTCT services

Yes

31

6.22

 

No

617

88.78

Adherence

Poor (<95%)

172

24.54

 

Good (>95%)

529

75.46

 

I

102

14.55

WHO stage

II

304

43.37

 

III

248

35.38

 

IV

47

6.70

  1. TB: tuberculosis, CCM: cryptococcal meningitis; KS, Kaposi’sarcoma; LIP, Lymphoid interstitial pnemonitis; PCP, pnenocystic carinii pneumonia; EFV, efaverenz; NVP, niverapine.